Trevi Therapeutics Inc - Ordinary Shares
News
Brokers Issue Forecasts for Trevi Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:TRVI)
Ticker Report Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) - Analysts at Leerink Partnrs issued their Q3 2024 earnings per share estimates for shares of Trevi Therapeutics in a research note issued on...\n more…
Jennifer L. Good Sells 4,219 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) Stock
Ticker Report Trevi Therapeutics, Inc. (NASDAQ:TRVI - Get Free Report) CEO Jennifer L. Good sold 4,219 shares of the firm's stock in a transaction on Friday, September 6th. The shares were sold at an average price...\n more…
Leerink Partners Initiates Coverage on Trevi Therapeutics (NASDAQ:TRVI)
Ticker Report Equities research analysts at Leerink Partners initiated coverage on shares of Trevi Therapeutics (NASDAQ:TRVI - Get Free Report) in a report released on Monday, MarketBeat Ratings reports. The...\n more…
Q1 2025 Earnings Estimate for Trevi Therapeutics, Inc. (NASDAQ:TRVI) Issued By Leerink Partnrs
Ticker Report Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for Trevi Therapeutics in a research note...\n more…
Trevi Therapeutics (NASDAQ:TRVI) Raised to "Strong-Buy" at Leerink Partnrs
Ticker Report Trevi Therapeutics (NASDAQ:TRVI - Get Free Report) was upgraded by investment analysts at Leerink Partnrs to a "strong-buy" rating in a note issued to investors on Monday, Zacks.com reports. Leerink...\n more…
